TUBB1相关巨血小板减少症与Glanzmann血小板无力症共存的家族
该家族先证者患I型Glanzmann血小板无力症(GT),伴出血时间延长、轻度先天性血小板减少及血小板大小异质性(含巨大血小板)。Sanger测序发现ITGB3基因两个杂合突变(p.P189S和p.C210S)致GT,高通量筛查另检出TUBB1基因杂合突变(p.G146R)与巨血小板减少症(MTP)相关。家系筛查证实该罕见表型为寡基因遗传,GT表型在临床上占主导。
要点
- GT患者出现血小板减少和巨大血小板时需考虑合并TUBB1等MTP相关基因突变。
- ITGB3双杂合突变(p.P189S和p.C210S)可致I型GT但不足以解释血小板增大。
- TUBB1 p.G146R杂合突变解释MTP,家系证实寡基因遗传且GT表型临床占优。
核心结论
- 该家族罕见表型由ITGB3和TUBB1基因突变寡基因遗传所致,GT表型在临床上占主导。
研究设计与样本
- 家族病例报告:对先证者行Sanger测序和高通量筛查,并行家系筛查验证。
主要发现
- 先证者有I型GT、出血时间延长、轻度先天性血小板减少及血小板大小异质性伴巨大血小板。
- Sanger测序检出ITGB3基因两个杂合突变p.P189S和p.C210S,均阻止αIIbβ3表达并致GT,但不解释血小板增大。
- 高通量筛查检出TUBB1基因杂合突变p.G146R,编码β1-微管蛋白,为已知MTP致病基因。
- 家系筛查证实该罕见表型源于寡基因遗传。
临床怎么用
- 对GT伴血小板减少和巨大血小板者,除ITGB3/ITGA2B外应筛查TUBB1等MTP相关基因。
- 家系筛查有助于明确寡基因遗传模式并指导遗传咨询。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Macrothrombocytopenia (MTP) is a rare but enigmatic complication of Glanzmann thrombasthenia (GT), an inherited bleeding disorder caused by the absence of platelet aggregation due to deficiencies of the αIIbβ3 integrin. OBJECTIVES: We report a family with type I GT and a prolonged bleeding time but unusually associated with congenital mild thrombocytopenia and platelet size heterogeneity with giant forms. METHODS AND RESULTS: Sanger sequencing of DNA from the propositus identified 2 heterozygous ITGB3 gene mutations: p.P189S and p.C210S both of which prevent αIIbβ3 expression and are causative of GT but without explaining the presence of enlarged platelets. High-throughput screening led to the detection of a predicted disease-causing heterozygous mutation in the TUBB1 gene: p.G146R, encoding β1-tubulin, a component of the platelet cytoskeleton and a gene where mutations are a known cause of MTP. CONCLUSIONS: Family screening confirmed that this rare phenotype results from oligogenic inheritance while suggesting that the GT phenotype dominates clinically.
引用
- Guillet B, Bayart S, Pillois X, et al. A Glanzmann thrombasthenia family associated with a TUBB1-related macrothrombocytopenia. J Thromb Haemost. 2019. PMID: 31565851. doi:10.1111/jth.14622
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。